ORM-5029

CAT: 0931-MF-0117524-01Size: 10 mgDry Ice: NoHazardous: No
CAT#:0931-MF-0117524-01Size:10 mg
Selected
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Target
Antibody-Drug Conjugates (ADCs)
Related Pathways
Antibody-drug Conjugate/ADC Related
Bioactivity
ORM-5029 is the first antibody-drug conjugate (ADC) targeting the human epidermal growth factor receptor 2 (HER2), combining the highly potent GSPT1 degrader SMol006 with Pertuzumab. It is applicable in cancer research.
Shipping Conditions
Cool pack
Storage Temperature
-20°C

Popular Products